COVALENT CROSS-LINKING OF NEUROFILAMENT PROTEINS BY OXIDIZED CATECHOLS AS A POTENTIAL MECHANISM OF LEWY BODY FORMATION

被引:56
作者
MONTINE, TJ
FARRIS, DB
GRAHAM, DG
机构
[1] Department of Pathology, Duke University Medical Center, Durham, NC
关键词
CATECHOLS; CROSS-LINKING; NEUROFILAMENTS; LEWY BODIES;
D O I
10.1097/00005072-199505000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brainstem Lewy bodies (LB) are neuronal inclusions that are closely related to Parkinson's disease (PD). The filamentous component of LB from patients with PD contains biochemically altered neurofilaments (NF). Herein we have tested the hypothesis that the oxidized products of catechols may covalently crosslink NE Neurofilaments were incubated in the presence of oxidized L-dopa, dopamine, or dopac and then analyzed by SDS-PAGE and protein staining or immunoblotting with monoclonal antibodies specific for neurofilament subunit proteins. Oxidized catechols yielded the same pattern of NF protein crosslinking as known covalent crosslinking agents. Coincubation of NF and catechols with N-proportional to-acetyI-L-Iysine (NAL) produced strong reactivity on immunoblots probed with a polyclonal antiserum specific for NAL crosslinked to protein (antiserum 1400/3). Crosslinking of NAL to model proteins by oxidized dopac was followed by antibody capture assays using antiserum 1400/3. Increasing immunoreactivity was observed for 0.01 to 1.0 mM dopac and was augmented by Cu2+, Fe2+, Fe3+, Mn2+, or Mn3+ up to 0.1 mM. These results show that the products of catechol oxidation can covalently crosslink neurofilaments, that the crosslinking mechanism can involve lysine, and that copper, iron, and manganese ions can accelerate catechol-mediated protein crosslinking.
引用
收藏
页码:311 / 319
页数:9
相关论文
共 44 条
  • [1] Gibb W.R.G., Lees A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry, 51, pp. 745-752, (1988)
  • [2] Gibb W., Lees A.J., The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease, Neuropathol Appl Neu-Robiol, 15, pp. 27-44, (1989)
  • [3] Dexter D.T., Carter C.J., Wells F.R., Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease, J Neurochem, 52, pp. 381-389, (1989)
  • [4] Di Monte D.A., Chan P., Sandy M.S., Gluathione in Parkinson's disease: A link between oxidative stress and mitochondrial damage?, Ann Neurol, 32, pp. S111-S115, (1992)
  • [5] Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D., Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group, Ann Neurol, 32, pp. S82-S87, (1992)
  • [6] Olanow C.W., Oxidative reactions in Parkinson's disease, Neurology, 40, pp. S32-S37, (1990)
  • [7] Schapira A.H.V., Mann V.M., Cooper J.M., Krige D., Jenner P.J., Marsden C.D., Mitochondrial function in Parkinson' disease, Ann Neurol, 32, pp. 116-124, (1992)
  • [8] Youdim M.B.H., Riederer P., The role of iron in senescence of dopaminergic neurons and Parkinson's disease, J Neural Transm, 40, pp. 57-67, (1993)
  • [9] Carlsson A., Fornstedt B., Possible mechanisms underlying the special vulnerability of dopaminergic neurons, Acta Neurol Scand, 84, pp. 16-18, (1991)
  • [10] Hirsch E., Graybiel A.M., Agid Y.A., Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease, Nature, 334, pp. 345-348, (1988)